BR112012014196A2 - agente para prevenir ou melhorar a pigmentação - Google Patents

agente para prevenir ou melhorar a pigmentação

Info

Publication number
BR112012014196A2
BR112012014196A2 BR112012014196A BR112012014196A BR112012014196A2 BR 112012014196 A2 BR112012014196 A2 BR 112012014196A2 BR 112012014196 A BR112012014196 A BR 112012014196A BR 112012014196 A BR112012014196 A BR 112012014196A BR 112012014196 A2 BR112012014196 A2 BR 112012014196A2
Authority
BR
Brazil
Prior art keywords
prevent
agent
atoms
improve pigmentation
carbon atoms
Prior art date
Application number
BR112012014196A
Other languages
English (en)
Other versions
BR112012014196B1 (pt
Inventor
Chihiro Kondo
Takashi Yamasaki
Yuko Saitoh
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Publication of BR112012014196A2 publication Critical patent/BR112012014196A2/pt
Publication of BR112012014196B1 publication Critical patent/BR112012014196B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/83Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

agente para prevenir ou melhorar a pigmentação. um objetivo da invenção é fornecer uma preparação externa para a pele, preferivelmente, usável para prevenir ou melhorar a pigmentação. o objetivo é obtido através do fornecimento de um agente para prevenir ou melhorar a pigmentação, consistindo de um composto representado pela fórmula geral (1) seguinte, um isômero do mesmo e/ou um sal farmacologicamente aceitável do mesmo, e de uma preparação externa para a pele contendo o mesmo como um componente: em que r~ 1~ representa um grupo aromático não substituído ou um grupo aromático que apresenta qualquer substituinte: r~ 2~ representa um átomo de hidrogênio, um grupo alquila de cadeia linear ou cadeia ramificada que apresenta vários átomos de carbono ou átomos de 1 a 4, ou um grupo acila que apresenta um alquila de cadeia linear ou ramificada que apresenta vários átomos de carbono ou átomos de 1 a 4; e r~ 3~ representa um átomo de hidrogênio ou um grupo alquila de cadeia linear ou cadeia ramificada que apresenta vários átomos de carbono ou átomos de 1 a 4.
BR112012014196-1A 2009-12-16 2010-12-16 Agente para prevenir ou melhorar a pigmentação BR112012014196B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009285001 2009-12-16
JP2009-285001 2009-12-16
PCT/JP2010/072689 WO2011074643A1 (ja) 2009-12-16 2010-12-16 色素沈着予防又は改善剤

Publications (2)

Publication Number Publication Date
BR112012014196A2 true BR112012014196A2 (pt) 2016-05-31
BR112012014196B1 BR112012014196B1 (pt) 2023-10-03

Family

ID=44167394

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012014196-1A BR112012014196B1 (pt) 2009-12-16 2010-12-16 Agente para prevenir ou melhorar a pigmentação

Country Status (17)

Country Link
US (2) US20120258063A1 (pt)
EP (1) EP2514402B1 (pt)
JP (1) JP5746977B2 (pt)
KR (1) KR101877575B1 (pt)
CN (1) CN102711720B (pt)
AU (1) AU2010331250B2 (pt)
BR (1) BR112012014196B1 (pt)
CA (1) CA2784308C (pt)
ES (1) ES2604104T3 (pt)
HK (1) HK1173662A1 (pt)
IL (1) IL220413B (pt)
MX (1) MX341841B (pt)
MY (1) MY179437A (pt)
RU (1) RU2564897C2 (pt)
SG (1) SG181702A1 (pt)
UA (1) UA111709C2 (pt)
WO (1) WO2011074643A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5908678B2 (ja) * 2011-06-14 2016-04-26 ポーラ化成工業株式会社 皮膚外用剤
JP6255154B2 (ja) * 2012-12-10 2017-12-27 ポーラ化成工業株式会社 皮膚外用剤
JP6249598B2 (ja) * 2012-12-10 2017-12-20 ポーラ化成工業株式会社 皮膚外用剤
CA3185776A1 (en) * 2014-04-03 2015-10-08 Pola Chemical Industries, Inc. Melanogenesis inhibitor comprising d-pantothenyl alcohol, and skin-whitening cosmetic containing same melanogenesis inhibitor
KR101651605B1 (ko) * 2015-12-10 2016-08-26 대봉엘에스 주식회사 신규 페놀산류 유도체 화합물, 및 이의 용도
EP3711746A4 (en) * 2017-11-15 2021-08-25 Pola Chemical Industries Inc. OIL BASED COMPOSITION
BR112020023802B1 (pt) * 2018-05-29 2023-10-31 Pola Chemical Industries, Inc Agente iluminador de pele

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3091270B2 (ja) 1990-09-28 2000-09-25 協和醗酵工業株式会社 美白化粧料
JP3736405B2 (ja) * 1992-12-21 2006-01-18 味の素株式会社 アミノ酸誘導体及び抗活性酸素剤
JP3091045B2 (ja) 1993-03-04 2000-09-25 丸善製薬株式会社 皮膚化粧料
GB9703201D0 (en) * 1997-02-15 1997-04-02 Zeneca Ltd Chemical compounds
JPH10298151A (ja) * 1997-04-30 1998-11-10 Japan Energy Corp C型肝炎ウイルスプロテアーゼ阻害剤
JPH1149630A (ja) * 1997-07-31 1999-02-23 Shiseido Co Ltd 美白用化粧料
JP3545173B2 (ja) * 1997-07-31 2004-07-21 アマノ株式会社 ダクト管用粉塵堆積防止装置
US5882665A (en) * 1997-11-18 1999-03-16 Elizabeth Arden Co., Division Of Conopco, Inc. Phytosphingosine salicylates in cosmetic compositions
US6238655B1 (en) 1997-12-15 2001-05-29 The Gillette Company α-amides of L-amino acid as fragrance precursors
JPH11310510A (ja) 1998-04-27 1999-11-09 Kanebo Ltd 保湿剤並びに皮膚化粧料及び入浴剤
JP2001247443A (ja) 2000-03-08 2001-09-11 Kanebo Ltd 皮膚化粧料
JP2002087928A (ja) 2000-09-18 2002-03-27 Kyowa Hakko Kogyo Co Ltd 化粧用保湿剤および化粧料
AU2003220896A1 (en) * 2002-03-28 2003-11-10 Sumitomo Pharmaceuticals Co., Ltd. Novel heteroaryl compounds
EP2184281A1 (en) 2002-05-29 2010-05-12 Eli Lilly & Company Phenyl-thiophene type vitamin D receptor modulators
CN1675154A (zh) 2002-06-07 2005-09-28 科蒂科股份有限公司 抑制巨噬细胞移动抑制因子(mif)的细胞因子或生物活性的萘衍生物
NZ537301A (en) 2002-06-07 2006-06-30 Cortical Pty Ltd Therapeutic molecules and methods-1
JP4286513B2 (ja) 2002-09-26 2009-07-01 株式会社ファンケル 抗老化用組成物
ES2317076T3 (es) 2003-12-08 2009-04-16 GALDERMA RESEARCH & DEVELOPMENT Derivados bifenilicos utiles como ligandos que activan receptores rar, procedimiento para prepararlos y su utilizacion en medicina humana y en cosmeticos.
DE602005025517D1 (de) * 2004-10-15 2011-02-03 Bayer Healthcare Llc Herstellung und anwendung von biphenyl-4-yl-carbonylaminosäurederivaten zur behandlung von obesitas
US20060166901A1 (en) 2005-01-03 2006-07-27 Yu Ruey J Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
JP5014592B2 (ja) * 2005-05-25 2012-08-29 株式会社 資生堂 不全角化抑制剤、毛穴縮小剤,肌荒れ防止・改善剤
EP1908454A1 (en) * 2005-07-26 2008-04-09 Shiseido Company, Ltd. Wrinkle-preventive/ameliorating agent
US8367664B2 (en) 2006-01-24 2013-02-05 Allergan, Inc. Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
AR062677A1 (es) * 2006-09-08 2008-11-26 Novartis Ag Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden

Also Published As

Publication number Publication date
IL220413B (en) 2018-07-31
HK1173662A1 (en) 2013-05-24
EP2514402A1 (en) 2012-10-24
IL220413A0 (en) 2012-08-30
US20120258063A1 (en) 2012-10-11
ES2604104T3 (es) 2017-03-03
RU2012129932A (ru) 2014-01-27
BR112012014196B1 (pt) 2023-10-03
CN102711720B (zh) 2014-08-27
AU2010331250A1 (en) 2012-08-02
CN102711720A (zh) 2012-10-03
CA2784308C (en) 2017-11-28
SG181702A1 (en) 2012-07-30
UA111709C2 (uk) 2016-06-10
WO2011074643A1 (ja) 2011-06-23
JP5746977B2 (ja) 2015-07-08
CA2784308A1 (en) 2011-06-23
MX2012006925A (es) 2012-07-17
KR20120092709A (ko) 2012-08-21
US9414998B2 (en) 2016-08-16
JPWO2011074643A1 (ja) 2013-04-25
RU2564897C2 (ru) 2015-10-10
MY179437A (en) 2020-11-06
KR101877575B1 (ko) 2018-07-12
AU2010331250B2 (en) 2015-07-30
EP2514402B1 (en) 2016-08-31
MX341841B (es) 2016-09-05
US20140322150A1 (en) 2014-10-30
EP2514402A4 (en) 2014-05-28

Similar Documents

Publication Publication Date Title
BR112012014196A2 (pt) agente para prevenir ou melhorar a pigmentação
BR112012014858A2 (pt) agente antiplaqueta
BR112012026950A2 (pt) composto, e, uso de um composto
BR112012003592B8 (pt) composição farmacêutica contendo derivado de quinolina
BRPI0720993B8 (pt) usos de compostos análogos de ciclopamina
BR112015009806A2 (pt) composições adjuvantes aquosas
UY31906A (es) Derivados de n-cicloalquil-3-fenilnicotinamida que inhiben pgds, sus composiciones, su uso para el tratamiento por ejemplo de afecciones alérgicas y respiratorias.
BR112012027385A2 (pt) composição para o controle de doenças de plantas e uso da mesma
BR112015001121A2 (pt) composição para controle de doença de planta e aplicação para a mesma
BR112012017157A2 (pt) agente profilático ou de melhora da pigmentação.
BR112017009168A2 (pt) derivado de tionucleosídeo ou sal deste e composição farmacêutica
BR112015001502A2 (pt) derivados de tipo azaindazol ou diazaindazol para tratamento de dor
BR112014000665B8 (pt) composto, composição farmacêutica, agente antimicrobiano, e, uso de um composto
BR112012027387A2 (pt) composição para controle de doenças de plantas e uso da mesma
BR112012033013A2 (pt) composição de controle de doenças de plantas e método de controle de doenças de plantas
BR112012019762A2 (pt) composto, composição, e, método para tratar uma doença.
BR112016007427A2 (pt) compostos de pirazol-amida e usos dos mesmos
BR112016013299A2 (pt) Composto
BR112012007090A2 (pt) inibidor da atividade da heparanase
BR112013006936A2 (pt) composto de amida substituída
BR112012027373A2 (pt) composição pesticida e seu uso
BRPI1011683B8 (pt) derivados de isoquinolina substituída, suas composições farmacêuticas e seus usos
BRPI0711818A2 (pt) novo composto com afinidade pela amilóide
BRPI0821653B8 (pt) composto de piridina substituída com anel heterocíclico e grupo fosfonoximetila ou um sal do mesmo, composição farmacêutica compreendendo-os e uso dos mesmos para tratar uma doença fungíca
BR112014007078A2 (pt) composição de controle de doença de plantas e seu uso

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/12/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.